Is cytology required for a hematuria evaluation?

Journal of Urology

Volumn 171, Issue 1, 2004, Pages 324-326

  Hofland, Chris A ^a   Mariani, Albert J ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Costs and cost analysis; Cytology; Hematuria; Urine

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COST BENEFIT ANALYSIS; CYSTOSCOPY; DIAGNOSTIC VALUE; FEMALE; HEALTH CARE POLICY; HEMATURIA; HUMAN; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

EID: 0347479277     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000100392.23046.17     Document Type: Article

References (5)

1. Brown, F. M.: Urine cytology: is it still the gold standard for screening? Urol Clin North Am, 27: 25, 2000
2. Grossfeld, G. D. and Carroll, P. R.: Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am, 25: 661, 1998
3. Grossfeld, G. D., Litwin, M. S., Wolf, J. S., Jr., Hricak, H., Shuler, C. L., Agerter, D. C. et al: Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology, 57: 604, 2001
4. Mariani, A. J., Mariani, M. C., Macchioni, C., Stams, U. K., Hariharan, A. and Moriera, A.: The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost effectiveness analysis. J Urol, 141: 350, 1989
5. Shandon Cytospin Operating Instruction Manual. Pittsburgh: Shandon Southern Instruments, Inc., 1972